RGLS Historical Earnings image   This RGLS historical earnings page last updated 8/19/2022
RGLS Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/11/2022NA
Q1 20225/12/2022NA
Q4 20213/10/2022NA
Q3 202111/10/2021NA
Q2 20218/10/2021NA
Q1 20215/13/2021NA
Q4 20203/9/20210.01B
Q3 202011/5/20200.01B
Q2 20208/13/2020NA
Q1 20205/14/20200.01M
Q4 20193/12/20200.02M
Q3 201911/12/20190.02M
Q2 20198/8/20190.02M
Q1 20195/9/20190.01B
Q4 20183/18/201918000
Q3 201811/8/201818000
Q2 20188/9/201818000
Q1 20185/10/201818000
Q4 20173/7/201818000
Q3 201711/7/201718000
Q2 20178/1/201718000
Q1 20175/4/201718000
Q4 20163/2/201718000
Q3 201611/1/2016204000
Q2 20168/2/2016483000
Q1 20165/2/2016489000
Q4 20152/22/201610.86M
Q3 201511/5/20151.86M
Q2 20158/4/20153.83M
Q1 20155/7/20154.20M
Q4 20142/18/20154.22M
Q3 201411/5/20141.10M
Q2 20148/6/2014736000
Q1 20145/8/20141.60M
Q4 20132/27/20145.45M
Q3 201311/13/20136.12M
Q2 20138/13/20134.76M
Q1 20135/14/20130.00B
Q4 20122/20/20133.24M
RGLS Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/11/2022-0.500
Q1 20225/12/2022-0.500
Q4 20213/10/2022-0.700
Q3 202111/10/2021-1.000
Q2 20218/10/2021-0.800
Q1 20215/13/2021-0.800
Q4 20203/9/2021-0.300
Q3 202011/5/2020-0.400
Q2 20208/13/2020-2.300
Q1 20205/14/2020-2.500
Q4 20193/12/2020-2.300
Q3 201911/12/2019-2.600
Q2 20198/8/2019-3.000
Q1 20195/9/2019-3.100
Q4 20183/18/2019-9.800
Q3 201811/8/2018-11.800
Q2 20188/9/2018-15.600
Q1 20185/10/2018-18.000
Q4 20173/7/2018-16.800
Q3 201711/7/2017-21.600
Q2 20178/1/2017-49.200
Q1 20175/4/2017-45.600
Q4 20163/2/2017-45.600
Q3 201611/1/2016-44.400
Q2 20168/2/2016-48.000
Q1 20165/2/2016-48.000
Q4 20152/22/2016-16.800
Q3 201511/5/2015-30.000
Q2 20158/4/2015-49.200
Q1 20155/7/2015-34.800
Q4 20142/18/2015-24.000
Q3 201411/5/2014-31.200
Q2 20148/6/2014-34.800
Q1 20145/8/2014-3.000
Q4 20132/27/2014-1.100
Q3 201311/13/2013-0.700
Q2 20138/13/2013-1.900
Q1 20135/14/2013-2.000
Q4 20122/20/2013-2.200
Quotes delayed 20 minutes

Email EnvelopeFree RGLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Regulus Therapeutics (RGLS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RGNX Historical Earnings
RIGL Historical Earnings
RLAY Historical Earnings
RLMD Historical Earnings
RLYB Historical Earnings
RMD Historical Earnings
RMED Historical Earnings
RMTI Historical Earnings
RNA Historical Earnings
RNAZ Historical Earnings
What was the record high RGLS historical earnings result?
In terms of earnings or revenue, what is the best RGLS historical earnings result that Regulus Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest RGLS historical earnings result was set in Q4 2020, when Regulus Therapeutics posted results of -0.300/share. The most successful revenue quarter within our data set was Q4 2015 when Regulus Therapeutics reported revenue of 10.86M.

What was the lowest Regulus Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest RGLS has reported, and when?

✔️Accepted answer: Within our data set, the lowest RGLS historical earnings result was set in Q2 2017, when Regulus Therapeutics posted results of -49.200/share. The smallest revenue quarter within our data set was Q2 2022 when Regulus Therapeutics reported revenue of NA.

On this page we presented the RGLS historical earnings date information for Regulus Therapeutics. Reviewing that RGLS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2020, when RGLS posted gaap of -0.300/share. Meanwhile the lowest RGLS historical earnings result was in Q2 2017, when RGLS posted gaap of -49.200/share. Moving to Regulus Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2015 when RGLS reported 10.86M in revenue, while the smallest revenue quarter was Q2 2022 when RGLS reported NA in revenue.

For self directed investors doing their due diligence on RGLS or any other given stock, their research can benefit from looking into all of the Regulus Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Regulus Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for RGLS. Thanks for visiting, and the next time you need to research RGLS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of ACE, Funds Holding Royal Caribbean Group, PHM Videos.

 

RGLS Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.